https://www.grants.gov/web/grants/view-opportunity.html?oppId=310486

White Papers due: between 1 February 2019 (Monday) with a deadline of 28 June 2019 (Friday) at 5:00 PM Eastern Time (required)

Applications due: 27 September 2019 (Friday) at 11:59 PM Eastern Time (by invitation, based on white paper assessment)

PROGRAM DESCRIPTION
The ONR seeks a broad range of applications for augmenting existing or developing innovative solutions that directly maintain, or cultivate a diverse, world-class STEM workforce in order to maintain the U.S. Navy and Marine Corps’ technological superiority. The goal of any proposed effort must provide solutions that will establish and maintain pathways of diverse U.S. citizens who are interested in uniformed or civilian DoN (or Navy and Marine Corps) STEM workforce opportunities.

As the capacity of the DoN Science and Technology (S&T) workforce is interconnected with the basic research enterprise and STEM education system, ONR recognizes the need to support efforts that can jointly improve STEM student outcomes and align educational efforts with Naval S&T current and future workforce needs. This announcement explicitly encourages projects that improve the capacity of education systems and communities to create impactful STEM educational experiences for students and workers. Submissions are encouraged to consider including active learning approaches and incorporating 21st century skill development. Projects must aim to increase student and worker engagement in STEM and enhance people with needed Naval STEM capabilities. ONR encourages applications to utilize current STEM educational research for informing project design and advancing our understanding of how and why people choose STEM careers and opportunities of naval relevance.

While this announcement is relevant for any stage of the STEM educational system, funding efforts will be targeted primarily toward projects addressing the below communities or any combination of these communities:

• Secondary education communities;
• Post-Secondary communities;
• Informal science communities;
• Current naval STEM workforce communities.

Full FOA available here: https://www.grants.gov/web/grants/view-opportunity.html?oppId=310486

Defense Health Program
Department of Defense Peer Reviewed Medical Research Program

Funding Opportunities for Fiscal Year 2019 (FY19)

The FY19 Defense Appropriations Act provides $350 million (M) to the Department of Defense Peer Reviewed Medical Research Program (PRMRP) to support or medical research projects of clear scientific merit and direct relevance to military health.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA), J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

FY19 PRMRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.

The vision and mission of the PRMRP is improve the health, care, and well-being of all military Service members, Veterans, and beneficiaries by encouraging, identifying, selecting, and managing medical research projects of clear scientific merit and direct relevance to military health.

Congressionally Directed Topic Areas:  All applications submitted to the PRMRP must address at least one of the FY19 PRMRP Congressionally directed topic areas.  The FY19 PRMRP Topic Areas are as follows:

• Acute Lung Injury
• Antimicrobial Resistance
• Arthritis
• Burn Pit Exposure
• Cardiomyopathy
• Cerebellar Ataxia
• Chronic Migraine and Post-Traumatic Headache
• Congenital Heart Disease
• Constrictive Bronchiolitis
• Diabetes
• Dystonia
• Eating Disorders
• Emerging Infectious Diseases
• Epidermolysis Bullosa
• Focal Segmental Glomerulosclerosis
• Frontotemporal Degeneration
• Guillain-Barré Syndrome
• Hemorrhage Control
• Hepatitis B
• Hereditary Angioedema
• Hydrocephalus
• Immunomonitoring of Intestinal Transplants
• Inflammatory Bowel Diseases
• Interstitial Cystitis
• Lung Injury
• Metals Toxicology
• Mitochondrial Disease
• Musculoskeletal Disorders
• Myotonic Dystrophy
• Nanomaterials for Bone Regeneration
• Nutrition Optimization
• Pancreatitis
• Pathogen-Inactivated Blood Products
• Polycystic Kidney Disease
• Post-Traumatic Osteoarthritis
• Pressure Ulcers
• Pulmonary Fibrosis
• Resilience Training
• Respiratory Health
• Rett Syndrome
• Rheumatoid Arthritis
• Scleroderma
• Sleep Disorders
• Spinal Muscular Atrophy
• Tinnitus
• Tissue Regeneration
• Tuberculosis
• Vascular Malformations
• Women’s Heart Disease

https://cdmrp.army.mil/funding/prmrp

Clinical Trial Award – Preproposal due March 14, 2019

• Assistant Professor level or above (or equivalent)

• Preproposal submission is required; application submission is by invitation only.
• Supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area(s) of interest.
• Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.

• Investigational New Drug or Investigational Device Exemption applications, if needed, should be approved by the Food and Drug Administration before the PRMRP application submission deadline.
• A copy of the FDA Acknowledgement letter and meeting minutes, if applicable, should be submitted with the full application.  If the trial will be conducted internationally, a copy of the relevant national regulatory agency approval should be submitted with the full application.

• No maximum funding limit; requested funding should be justifiable and appropriate for the scope of work proposed; budget will be considered during pre-application screening and will be a scored full application criterion.

• Maximum period of performance is 4 years

Discovery Award – Letter of Intent due March 28, 2019

• Postdoctoral fellow or clinical fellow (or equivalent) and above

• Supports the exploration of a highly innovative new concept or untested theory in the Topic Are(s) of interest.
• Not intended to support the logical progression of an already established line of questioning.
• Clinical trials will not be funded.

• Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborator(s), and their organization(s).

• Maximum funding of $200,000 for direct costs (plus indirect costs)

• Maximum period of performance is 2 year

Focused Program Award – Preproposal due March 14, 2019

• Lead PI: Full Professor level or above (or equivalent)
• Project Leads: Assistant Professor level or above (or equivalent)

• Preproposal submission is required; application submission is by invitation only.
• Supports a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal in the Topic Area(s) of interest.
• Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications.
• Projects may range from exploratory/hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question.

• Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects.

• Maximum funding of $7.2 million for direct costs (plus indirect costs)

• Maximum period of performance is 4 years

Investigator-Initiated Research Award – Preproposal due March 14, 2019

• Assistant Professor level or above (or equivalent)

• Preproposal submission is required; application submission is by invitation only.
• Supports research that will make an original and important contribution to the field of research or patient care in the Topic Area(s) of interest.
• Partnering PI Option available.

• Clinical trials will not be funded.

• Maximum funding of  $1.2 million for direct costs (plus indirect costs); $1.5 million for direct costs (plus indirect costs) for applications including a Partnering PI Option

• Maximum period of performance is 3 years

Technology/ Therapeutic Development Award – Preproposal due March 14, 2019

• Assistant Professor level or above (or equivalent)

• Supports the translation of promising preclinical findings into clinical applications for prevention, detection, diagnosis, treatment, or quality of life in the Topic Area(s) of interest.
• Product-oriented (e.g., device, drug, clinical guidelines).  The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product.
• Clinical trials will not be funded.

• Preproposal submission is required; application submission is by invitation only.

• Maximum funding of $3.0 million for direct costs (plus indirect costs)

• Maximum period of performance is 3 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

Combat Readiness – Medical Research Program (CRRP)

Fiscal Year 2019 State of the Science

A Combat Readiness – Medical Research Program (CRRP) for Fiscal Year (FY) 2019 has been included in the United States FY19 Department of Defense appropriation at $15 Million (M). The CRRP will be established as a program of the Congressionally Directed Medical Research Programs (CDMRP) to research forward-deployable solutions that can promptly address life threatening injuries and medical diagnostics, threats, and treatments, and medical threats and treatments for Service members in battlefield settings.

To efficiently manage CRRP, the CDMRP will utilize its two tiered review process (http://cdmrp.army.mil/about/2tierRevProcess).  Traditionally for new programs, the CDMRP holds an inaugural Stakeholders meeting where experts from different subject areas are brought together to identify knowledge gaps, outcome and product needs for the state of the science and patient care, etc. After the Stakeholders Meeting, a Vision Setting meeting is held to recommend an investment strategy to answer some of the unmet medical needs, knowledge gaps, and consumer concerns. In order to expedite the process, the CDMRP is currently soliciting information on the identification of current research efforts and knowledge gaps in medical planning and resources for providing wounded Service members lifesaving care within the “golden hour” after an injury occurs, as well as medical capabilities that may mitigate fatalities.

Medical combat readiness focuses on the immediate medical needs of the warfighter on the battlefield following life-threatening injury or environmental exposure. Injuries or exposures include, but are not limited to, neurological injuries, hemorrhage, and exposures to chemical and biological threats. In order to address the diagnosis and treatment of battlefield injuries, there is urgent need for forward- and rapidly-deployable diagnostics, therapeutics, telemedicine (to include monitoring and data transfer technologies), and countermeasures to chemical and infectious disease exposures.

Please take the time to answer the following survey on medical combat readiness research, the state of the science, and medical care. Consider in your answers the program’s Congressional direction to support military-relevant advanced technology and therapeutic research related to the following focus areas:

(1)   Enhancing battlefield diagnostics for neurological injuries and hemorrhage;

(2)   Integrated wound care and tissue regeneration therapies;

(3)   Environmental and wearable sensors, combined with advanced computing, for surveillance and monitoring of chemical and biological threat exposures;

(4)   Telemedicine applications for battlefield medicine, to allow for better collection, integration, and transfer of patient data from battlefield medical units through transport and treatment;

(5)   Chemical and biological exposure, countermeasures, and management strategies; and

(6)   Solutions for infectious disease management, including sepsis.

Provide answers within your area(s) of expertise and aligned with these topics identified by the CRRP. All answers should be submitted by January 31, 2019.

Do not include classified or sensitive information in your answers.

If the above hyperlink does not redirect you, please copy and paste the following URL:

https://www.surveymonkey.com/r/ZQMRSMM

Questions about this survey and the CRRP should be directed to the CDMRP public affairs mailbox at usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil.

Sincerely,

Combat Readiness – Medical Research Program, CDMRP

SURVEY QUESTIONS:

1. What cutting edge and forward-looking research could make a significant impact on addressing the medical needs of the warfighter on the battlefield?
2. What existing technology solutions currently exist? What technology needs to be developed?
3. What basic research is primed to move towards development of technology solutions?
4. What are the needs and considerations for deploying solutions in a civilian (e.g. first responders, rural environments, etc.) versus military environment?

Defense Health Program
Department of Defense Breast Cancer Research Program
Funding Opportunities for Fiscal Year 2019 (FY19)

The FY19 Defense Appropriation provides $130 million (M) to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).
The BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY19 BCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in January 2019. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
Applications submitted to the FY19 BCRP must address one or more of the following overarching challenges:
• Prevent breast cancer (primary prevention)
• Identify determinants of breast cancer initiation, risk, or susceptibility
• Distinguish deadly from non-deadly breast cancers
• Conquer the problems of overdiagnosis and overtreatment
• Identify what drives breast cancer growth; determine how to stop it
• Identify why some breast cancers become metastatic
• Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence
• Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
• Eliminate the mortality associated with metastatic breast cancer

https://cdmrp.army.mil/pubs/press/2019/19bcrppreann

Breakthrough Award
• Investigators at all academic levels (or equivalent)
• Senior postdoctoral fellows who do not meet the eligibility requirements of the Breakthrough Fellowship
• Award are encouraged to apply under Funding Levels 1 and 2
• Supports promising research that has high potential to lead to or make breakthroughs in breast cancer.
• Potential impact of the research may be near-term or long-term, but it must move beyond a minor advancement and have the potential to lead to a new approach that is fundamentally better than interventions already approved or in clinical development.
• Partnering PI Option allows two Principal Investigators (PIs), termed Initiating and Partnering PIs, to collaborate on a single application.
• Different funding levels, based on the scope of research, are available. It is the responsibility of the PI to select the funding level that is most appropriate for the research proposed. The funding level should be selected based on the scope of the research project, rather than the amount of the budget.
The following are general descriptions, although not all-inclusive, of the scope of research projects that would be appropriate to propose under each funding level:
• Funding Level 1: Innovative, high-risk/high-reward research that is in the earliest stages of idea development. In order to foster research with clearly defined potential to yield new avenues of investigation, preliminary data are not required. Proof-of-concept is the anticipated outcome.
• Funding Level 2: Preclinical research that is already supported by substantial preliminary or published data and strongly validates clinical translation in a well-defined context within the breast cancer landscape.
• Funding Level 2 – Population Science and Prevention Studies: With compelling justification, population science and prevention studies may request higher levels of funding and an additional year in the period of performance. Such studies may require additional resources due to the participation of human subjects and/or use of human biospecimens.
• Funding Level 3: Advanced translational studies with a high degree of project readiness. Where relevant, proof of availability of and access to necessary data, human samples, cohort(s), and/or critical reagents must be provided. If the proposed research would ultimately require US Food and Drug Administration (FDA) involvement, applications must demonstrate availability of and access to clinical reagents (e.g. therapeutic molecules) and subject population(s). Applications must state a realistic timeline for near-term clinical investigation. Small-scale clinical trials (e.g. first in human; Phase I/Ib) may be appropriate.
• Funding Level 4: Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer. Human clinical trials are required. PIs are expected to have experience in successfully leading large-scale projects and demonstrated ability (through personal experience or via a commitment from a collaborating clinical investigator) to implement a clinical project successfully. Where relevant, applications must demonstrate availability of and access to necessary data, human samples, cohort(s), and/or critical reagents. For proposed research that will require FDA involvement, project readiness requirements at the time of application submission include: proof of availability of and access to clinical reagents (e.g. therapeutics) that meet regulatory compliance guidelines; proof of availability of and access to appropriate subject population(s); validated projections for patient recruitment; and submission of an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the FDA, if applicable.
Funding Levels 1 and 2:
• Submission of a Letter of Intent is required prior to full application submission.
• Each PI may submit only one application as a PI or Initiating PI for each funding level. There are no limitations on the number of applications for which an investigator may be named as a Partnering PI. However, applicants are discouraged from submitting as a Partnering PI on multiple applications unless they are clearly unique, meaningful collaborations addressing distinct research questions.
• Additional funds are available for applications submitted under the Partnering PI Option.
• Clinical trials are not allowed.
Funding Levels 3 and 4:
• Submission of a preproposal is required; application submission is by invitation only.
• Each PI may submit only one application as a PI or Initiating PI for each funding level. There are no limitations on the number of applications for which an investigator may be named as a Partnering PI. However, applicants are discouraged from submitting as a Partnering PI on multiple applications unless they are clearly unique, meaningful collaborations addressing distinct research questions.
• Additional funds are available for Funding Level 3 applications submitted under the Partnering PI Option.
• PIs must include two or more breast cancer advocates on their research team.
Clinical trials are allowed (Funding Level 3) or required (Funding Level 4).
Funding Level 1:
Maximum funding of $450,000 for direct costs (plus indirect costs)
Maximum period of performance is 3 years
Funding Level 1 – Partnering PI Option:
Maximum funding of $750,000 for direct costs (plus indirect costs)
Maximum period of performance is 3 years
Funding Level 2:
Maximum funding of $1 million (M) for direct costs (plus indirect costs)
Maximum period of performance is 3 years
Funding Level 2 – Partnering PI Option:
Maximum funding of $1.5M for direct costs (plus indirect costs)
Maximum period of performance is 3 years
Funding Level 2 – Population Science and Prevention Studies
Maximum funding of $1.5M for direct costs (plus indirect costs)
Maximum period of performance is 4 years
Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option
Maximum funding of $2M for direct costs (plus indirect costs)
Maximum period of performance is 4 years
Funding Level 3:
Maximum funding of $3M in direct costs (plus indirect costs)
Maximum period of performance is 4 years
Funding Level 3 – Partnering PI Option:
Maximum funding of $4M for direct costs (plus indirect costs)
Maximum period of performance is 4 years
Funding Level 4 and Funding Level 4 – Partnering PI Option:
Maximum funding of $10M for direct costs (plus indirect costs)
Maximum period of performance is 4 years

Breakthrough Fellowship Award
As of the application submission deadline, all eligible PIs must have:
• Successfully completed the requirements for a doctoral or medical degree, and
• Been in the laboratory or clinical research setting in which the proposed research is to be performed for no more than 2 years, and
• A total of less than 4 years’ experience in a postdoctoral fellowship or mentored clinical research training program (excludes any clinical residency or fellowship training)
Mentor
• Must have breast cancer research experience, including current funding and recent publications

• Supports exceptionally talented, “best and brightest” recent doctoral or medical graduates in pursuit of innovative, high-impact breast cancer research.
• Proposed research must have high potential to lead to or make breakthroughs in breast cancer and show evidence of rigorous experimental design, sufficient experimental details, appropriate controls, pitfalls and alternatives, and a statistical plan.
• Individualized researcher development plan and mentorship should prepare the PI for an independent career at the forefront of breast cancer research or patient care.
• The PI is not required to have previous experience in breast cancer research.
• Submission of a Letter of Intent is required prior to full application submission.
• Maximum funding of $300,000 for direct costs (plus indirect costs)
• Maximum period of performance is 3 years

Era of Hope Scholar Award
• Independent, non-mentored investigators within 6 years of their last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of the application submission deadline
• Supports exceptionally talented, early-career scientists who have demonstrated that they are the “best and brightest” in their fields through extraordinary creativity, vision, innovation, and productivity.
• PIs should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.
• PIs must demonstrate experience in forming effective partnerships and collaborations and exhibit strong potential for future leadership in breast cancer.
• PIs are required to include two or more breast cancer advocates on their research team.
• Submission of a Letter of Intent is required prior to full application submission.
• Maximum funding of $3M for direct costs (plus indirect costs)
• Maximum period of performance is 4 years

Innovator Award
• Associate Professor or above (or equivalent).
• Supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field.
• Provides opportunity to pursue novel, visionary, high-risk ideas that will accelerate progress toward ending breast cancer.
• PIs must include two or more breast cancer advocates on their research team.
Submission of a preproposal is required; application submission is by invitation only.
• Maximum funding of $5M for direct costs (plus indirect costs).
• Maximum period of performance is 4 years

Distinguished Investigator Award
• Assistant Professor or above (or equivalent) and more than 6 years beyond the PI’s last training position as of the application submission deadline
• Seeks new paradigms in breast cancer research by supporting investigators who are established and recognized leaders with a renowned reputation as a researcher who has made groundbreaking contributions to advancing their field and who propose a fundamental shift from their track record of research.
• Does not support continuation of or incremental changes from the PI’s published line of research. A shift from a different malignancy to breast cancer may not constitute a fundamental shift.
• If the PI is not an established breast cancer researcher, he/she must clearly articulate a motivation and commitment for proposing a conceptual shift in his/her research and must include at least one collaborator with breast cancer expertise.
• PIs must include two or more breast cancer advocates on their research team.
• High-risk/high-reward projects pursuing innovative new paradigms are encouraged, but not required.
• Submission of a preproposal is required; application submission is by invitation only.
• Maximum funding of $3M for direct costs (plus indirect costs)
• Maximum period of performance is 4 years
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil

Political Science

Full Proposal Target Date: January 15, 2019
Annually Thereafter

Program Guidelines: PD 98-1371
The Political Science Program supports scientific research that advances knowledge and understanding of citizenship, government, and politics. Research proposals are expected to be theoretically motivated, conceptually precise, methodologically rigorous, and empirically oriented. Substantive areas include, but are not limited to, American government and politics, comparative government and politics, international relations, political behavior, political economy, and political …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5418&WT.mc_id=USNSF_39&WT.mc_ev=click

Research on the Science and Technology Enterprise: Statistics and Surveys – R&D, U.S. S&T Competitiveness, STEM Education, S&T Workforce

Full Proposal Deadline Date: January 15, 2019

Program Guidelines: NSF 15-521
The National Center for Science and Engineering Statistics (NCSES) of the National Science Foundation (NSF) is one of the thirteen principal federal statistical agencies within the United States. It is responsible for the collection, acquisition, analysis, reporting and dissemination of objective, statistical data related to the science and engineering enterprise in the United States and other nations that is relevant and useful to practitioners, researchers, policymakers and the …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5265&WT.mc_id=USNSF_39&WT.mc_ev=click

Social Psychology

Full Proposal Target Date: January 15, 2019

Program Guidelines: PD 98-1332
The Social Psychology Program at NSF supports basic research on human social behavior, including cultural differences and development over the life span.
Among the many research topics supported are: attitude formation and change, social cognition, personality processes, interpersonal relations and group processes, the self, emotion, social comparison and social influence, and the …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5712&WT.mc_id=USNSF_39&WT.mc_ev=click

Sociology

Full Proposal Target Date: January 15, 2019
Regular Research

Program Guidelines: PD 98-1331
The Sociology Program supports basic research on all forms of human social organization — societies, institutions, groups and demography — and processes of individual and institutional change. The Program encourages theoretically focused empirical investigations aimed at improving the explanation of fundamental social processes. Included is research on organizations and organizational behavior, population dynamics, social movements, social groups, labor force participation, …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5369&WT.mc_id=USNSF_39&WT.mc_ev=click

Cultural Anthropology Program – Doctoral Dissertation Research Improvement Grants (CA-DDRIG)

Full Proposal Target Date: January 15, 2019

Program Guidelines: NSF 15-556
The primary objective of the Cultural Anthropology Program is to support basic scientific research on the causes, consequences, and complexities of human social and cultural variability.
Anthropological research spans a wide gamut, and contemporary cultural anthropology is an arena in which diverse research traditions and methodologies are valid. Recognizing the breadth of the field’s contributions to science, the Cultural Anthropology Program welcomes proposals …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505057&WT.mc_id=USNSF_39&WT.mc_ev=click

Cultural Anthropology Program Senior Research Awards (CA-SR)

Full Proposal Target Date: January 15, 2019

Program Guidelines: NSF 18-560
The primary objective of the Cultural Anthropology Program is to support fundamental, systematic anthropological research and training to increase understanding of the causes, consequences, and complexities of human social and cultural variability. The Cultural Anthropology Program welcomes proposals from researchers in all sub-fields of cultural anthropology and research at any temporal and spatial scale. Methodologies and approaches employed may include ethnographic field research, …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505513&WT.mc_id=USNSF_39&WT.mc_ev=click

Developmental Sciences (DS)

Full Proposal Target Date: January 15, 2019

Program Guidelines: PD 08-1698
DS supports basic research that increases our understanding of cognitive, linguistic, social, cultural, and biological processes related to human development across the lifespan. Research supported by this program will add to our knowledge of the underlying developmental processes that support social, cognitive, and behavioral functioning, thereby illuminating ways for individuals to live productive lives as members of society.
DS supports research that addresses developmental …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=8671&WT.mc_id=USNSF_39&WT.mc_ev=click

Formal Methods in the Field (FMitF)

Full Proposal Target Date: January 15, 2019

Program Guidelines: NSF 18-596
The Formal Methods in the Field (FMitF) program aims to bring together researchers in formal methods with researchers in other areas of computer and information science and engineering to jointly develop rigorous and reproducible methodologies for designing and implementing correct-by-construction systems and applications with provable guarantees. FMitF encourages close collaboration between two groups of researchers. The first group consists of researchers in the area of formal methods, …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505518&WT.mc_id=USNSF_39&WT.mc_ev=click

Linguistics

Full Proposal Target Date: January 15, 2019

Program Guidelines: PD 98-1311
The Linguistics Program supports basic science in the domain of human language, encompassing investigations of the grammatical properties of individual human languages, and of natural language in general. Research areas include syntax, semantics, morphology, phonetics, and phonology.
The program encourages projects that are interdisciplinary in methodological or theoretical perspective, and that address questions that cross disciplinary boundaries, …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5408&WT.mc_id=USNSF_39&WT.mc_ev=click

Linguistics Program – Doctoral Dissertation Research Improvement Awards (Ling-DDRI)

Full Proposal Target Date: January 15, 2019

Program Guidelines: NSF 14-551
The Linguistics Program supports basic science in the domain of human language, encompassing investigations of the grammatical properties of individual human languages, and of natural language in general. Research areas include syntax, linguistic semantics and pragmatics, morphology, phonetics, and phonology.
The program encourages projects that are interdisciplinary in methodological or theoretical perspective, and that address questions that cross disciplinary boundaries, such as …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505033&WT.mc_id=USNSF_39&WT.mc_ev=click

Accelerating Discovery: Educating the Future STEM Workforce (AD)

Full Proposal Window: January 16, 2019

Program Guidelines: PD 18-1998
A well-prepared, innovative science, technology, engineering, and mathematics (STEM) workforce is crucial to the Nation’s prosperity and security. Future generations of STEM professionals are a key sector of this workforce, especially in the critical scientific areas described in the Big Ideas for Future NSF Investments. To accelerate progress in these areas, the …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505552&WT.mc_id=USNSF_39&WT.mc_ev=click

Cultural Anthropology Scholars Awards

Full Proposal Target Date: January 16, 2019

Program Guidelines: NSF 07-544
The National Science Foundation announces an opportunity for methodological training by cultural anthropologists who are active researchers. The purpose is to help cultural anthropologists upgrade their methodological skills by learning a specific analytical technique which will improve their research abilities.
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5321&WT.mc_id=USNSF_39&WT.mc_ev=click

Expeditions in Computing

Full Proposal Deadline Date: January 16, 2019
Expeditions

Program Guidelines: NSF 18-528
The far-reaching impact and rate of innovation in the computer and information science and engineering fields has been remarkable, generating economic prosperity and enhancing the quality of life for people throughout the world.
The Directorate for Computer and Information Science and Engineering (CISE) has established the Expeditions in Computing (Expeditions) program to provide the CISE research and education community with the opportunity to pursue ambitious, …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503169&WT.mc_id=USNSF_39&WT.mc_ev=click

Gen-4 Engineering Research Centers (ERC)

Preliminary Proposal Deadline Date: January 16, 2019

Program Guidelines: NSF 19-503
The ERC program supports convergent research that will lead to strong societal impact. Each ERC has interacting foundational components that go beyond the research project, including engineering workforce development at all participant stages, a culture of diversity and inclusion where all participants gain mutual benefit, and value creation within an innovation ecosystem that will outlast the lifetime of the ERC. The logical reasoning that links the proposed activities to the identified goals …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505599&WT.mc_id=USNSF_39&WT.mc_ev=click

Joint DMS/NLM Initiative on Generalizable Data Science Methods for Biomedical Research (DMS/NLM)

Full Proposal Window: January 16, 2019

Program Guidelines: NSF 19-500
The Division of Mathematical Sciences (DMS) in the Directorate for Mathematical and Physical Sciences (MPS) at the National Science Foundation (NSF) and the National Library of Medicine (NLM) at the National Institutes of Health (NIH) plan to support the development of innovative and transformative mathematical and statistical approaches to address important data-driven biomedical and health challenges. The rationale for this interagency collaboration is that significant …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505604&WT.mc_id=USNSF_39&WT.mc_ev=click

Science of Learning (SL)

Full Proposal Deadline Date: January 16, 2019

Program Guidelines: PD 16-004Y
The Science of Learning program supports potentially transformative basic research to advance the science of learning. The goals of the SL Program are to develop basic theoretical insights and fundamental knowledge about learning principles, processes and constraints. Projects that are integrative and/or interdisciplinary may be especially valuable in moving basic understanding of learning forward but research with a single discipline or methodology is also appropriate if it …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5567&WT.mc_id=USNSF_39&WT.mc_ev=click

Partnerships for Innovation (PFI)

Full Proposal Deadline Date: January 17, 2019

Program Guidelines: NSF 19-506
The Partnerships for Innovation (PFI) Program within the Division of Industrial Innovation and Partnerships (IIP) offers researchers from all disciplines of science and engineering funded by NSF the opportunity to perform translational research and technology development, catalyze partnerships and accelerate the transition of discoveries from the laboratory to the marketplace for societal benefit.
PFI has five broad goals, as set forth by the American Innovation and Competitiveness …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=504790&WT.mc_id=USNSF_39&WT.mc_ev=click

Scalable Parallelism in the Extreme (SPX)

Full Proposal Deadline Date: January 17, 2019

Program Guidelines: NSF 19-505
Computing systems have undergone a fundamental transformation from the single-core processor-devices of the turn of the century to today’s ubiquitous and networked devices with multicore/many-core processors along with warehouse-scale computing via the cloud. At the same time, semiconductor technology is facing fundamental physical limits and single-processor performance has plateaued. This means that the ability to achieve performance improvements through improved processor technologies …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505348&WT.mc_id=USNSF_39&WT.mc_ev=click

Decision, Risk and Management Sciences (DRMS)

Full Proposal Target Date: January 18, 2019
January 18, Annually Thereafter

Program Guidelines: PD 98-1321
The Decision, Risk and Management Sciences program supports scientific research directed at increasing the understanding and effectiveness of decision making by individuals, groups, organizations, and society. Disciplinary and interdisciplinary research, doctoral dissertation research improvement grants (DDRIGs), and workshops are funded in the areas of judgment and decision making; decision analysis and decision aids; risk analysis, perception, and communication; societal and public policy …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5423&WT.mc_id=USNSF_39&WT.mc_ev=click

Economics

Full Proposal Target Date: January 18, 2019

Program Guidelines: PD 98-1320
The Economics program supports research designed to improve the understanding of the processes and institutions of the U.S. economy and of the world system of which it is a part. This program also strengthens both empirical and theoretical economic analysis as well as the methods for rigorous research on economic behavior. It supports research in almost every area of economics, including econometrics, economic history, environmental economics, finance, industrial organization, international …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5437&WT.mc_id=USNSF_39&WT.mc_ev=click

Long Term Ecological Research (LTER)

Letter of Intent Target Date: January 18, 2019

Program Guidelines: NSF 19-544
NSF invites proposals for a Long Term Ecological Research (LTER) Network Coordination Office. This office will coordinate network level activities, including synthetic research, education, and outreach programs across the 28 LTER research sites, communicate these activities to diverse audiences, and provide centralized representation of the LTER network to the broad scientific community and the public. The lead PI of the successful proposal will serve as the Office Director and will work …
More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505103&WT.mc_id=USNSF_39&WT.mc_ev=click